政府对GLP-1激动剂在代谢综合征精神健康患者中的补贴：呼吁改善生活质量和降低成本

{"title":"政府对GLP-1激动剂在代谢综合征精神健康患者中的补贴：呼吁改善生活质量和降低成本","authors":"Wole Akosile","doi":"10.1177/10398562251313696","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"578"},"PeriodicalIF":1.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12138133/pdf/","citationCount":"0","resultStr":"{\"title\":\"Government subsidies for GLP-1 agonists in mental health patients with metabolic syndrome: A call for quality-of-life improvement and cost reduction.\",\"authors\":\"Wole Akosile\",\"doi\":\"10.1177/10398562251313696\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8630,\"journal\":{\"name\":\"Australasian Psychiatry\",\"volume\":\" \",\"pages\":\"578\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12138133/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Australasian Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10398562251313696\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australasian Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10398562251313696","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}